title: The relationship of serovar to clinical manifestations of urogenital Chlamydia trachomatis infection.
abstract: OBJECTIVE
  Studies assessing the relationship of serovars or genotypes to clinical manifestations of urogenital disease have produced contradictory results. Possible reasons for this include small sample sizes insufficient to reliably detect associations and failure to address potential confounding factors. Utilizing a large dataset and multivariate analysis to address confounding factors, we undertook this study of the relationship of chlamydial serovars to specific clinical manifestations of urogenital disease.
  
  
  METHODS
  This was a cross-sectional study of 480 women and 700 heterosexual men with urogenital chlamydial infection attending a sexually transmitted diseases clinic from 1995 to 1999 and a literature review.
  
  
  RESULTS
  Women (89%) and men (86%) were infected predominately with serovars D, E, F, Ia, and J. After controlling for age and race, we found that women who reported abdominal pain and/or dyspareunia were more often infected with serovar F (P= 0.048). An association of specific clinical manifestations with serovars was not detected in men.
  
  
  CONCLUSIONS
  We conclude that clinical manifestations of urogenital infection are not strongly influenced by the infecting serovar.
authors.affiliation: Division of Allergy and Infectious Diseases, University of Washington, Seattle, Washington 98195, USA.
authors.forename: William M
authors.initials: WM
authors.lastname: Geisler
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Suchland
authors.forename: William L H
authors.initials: WL
authors.lastname: Whittington
authors.forename: Walter E
authors.initials: WE
authors.lastname: Stamm
mesh_terms: D015746:Abdominal Pain; D000328:Adult; D002690:Chlamydia Infections / Q000382:microbiology / Q000503:physiopathology*; D002692:Chlamydia trachomatis / Q000145:classification* / Q000302:isolation & purification / Q000472:pathogenicity*; D004414:Dyspareunia; D005260:Female; D052776:Female Urogenital Diseases / Q000382:microbiology / Q000503:physiopathology*; D006801:Humans; D008297:Male; D052801:Male Urogenital Diseases; D012703:Serotyping; D014774:Virulence